- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Programmed death-ligand 1 (CD274), commonly known as PD-L1, is a type I transmembrane immune checkpoint protein expressed on tumor cells and antigen-presenting cells that regulates T cell activation through interaction with PD-1. PD-L1 Antibody for FACS / CD274 Flow Cytometry Antibody is optimized for detection of PD-L1 on the cell surface, enabling high-resolution analysis of immune checkpoint expression across heterogeneous cell populations. Its role in tumor immune evasion and immune regulation makes PD-L1 a central target for flow cytometry-based studies of the tumor microenvironment and immune cell activation states.
PD-L1 antibody, also referred to as CD274 antibody or B7-H1 antibody, produces strong and well-defined cell surface staining in flow cytometry assays, allowing clear identification of PD-L1-positive cells. In FACS analysis, PD-L1 expression is detected on tumor cells, macrophages, dendritic cells, and activated lymphocyte populations. The antibody enables distinct separation of positive and negative populations, supporting precise gating and quantitative assessment of PD-L1 expression levels in mixed cell samples.
This clone is further distinguished by protein microarray specificity validation using a HuProt(TM) platform containing more than 19,000 full-length human proteins. Clone PDL1/2743 demonstrates highly selective binding to PD-L1 with a dominant signal and strong Z-score separation from all secondary targets, indicating minimal cross-reactivity. This high level of specificity is particularly critical in flow cytometry, where non-specific binding can lead to false-positive populations, reduced resolution, and inaccurate gating. The validated specificity profile supports confident interpretation of PD-L1-positive cell populations in complex samples.
In flow cytometry experiments, PD-L1 expression is typically evaluated as a right-shifted fluorescence signal relative to isotype or unstained controls. A clear and reproducible shift enables reliable discrimination of PD-L1-expressing cells and supports downstream quantitative analysis, including assessment of expression intensity and population frequency. This is especially important in immune profiling studies where PD-L1 expression levels may vary across cell subsets or in response to cytokine stimulation.
PD-L1 expression is dynamically regulated and can be upregulated by inflammatory signals such as interferon-gamma, resulting in variable expression across cell types and experimental conditions. Its localization to the plasma membrane makes it well suited for detection in live or fixed cell preparations, further supporting its use in flow cytometry applications.
Overall, PD-L1 Antibody for FACS provides high-confidence, high-resolution detection of CD274 expression with strong cell surface staining, clear population separation, and minimal background. Supported by microarray specificity validation, this antibody enables accurate identification and quantification of PD-L1-positive cell populations in immunology and cancer research studies.
This PD-L1 antibody is part of a broader PD-L1 antibody panel offered by NSJ Bioreagents.
Optimal dilution of the PD-L1 Antibody for FACS / CD274 Flow Cytometry Antibody should be determined by the researcher.
A portion of amino acids 39-191 from the human protein was used as the immunogen for this PD-L1 antibody.
Store the PD-L1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
CD274 antibody, PD-L1 antibody, B7-H1 antibody, Programmed death-ligand 1 antibody, PDCD1 ligand antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.